Showing results (331-340 of 515) with videos related to

Sort By:
Pageof 52
Crohn'S & Colitis 360|January 19, 2026
Oral Microbial Diversity is Associated with Biologic Treatment and Metabolic Health Status but not with Disease Activity in Patients with Inflammatory Bowel DiseaseGabrielle Wark, Nadeem O Kaakoush, Dorit Samocha-Bonet, et al.
Crohn'S & Colitis 360|February 4, 2026
Awareness of inflammatory bowel disease-associated colorectal cancer risk and its management in patients with inflammatory bowel disease: a systematic reviewFiza Khan, Christine Norton, Wladyslawa Czuber-Dochan
Crohn'S & Colitis 360|December 16, 2024
Clinical Course of Isolated Recurrent, Persistent Complex Perianal Fistulas Without Luminal Crohn's Disease: A Multicenter Case Series of 24 PatientsHannah W Fiske, Chung Sang Tse, Badr Al-Bawardy, et al.
Crohn'S & Colitis 360|December 20, 2024
Mycophenolate Mofetil Appears Effective for the Treatment of Patients With Refractory Crohn's DiseaseSam Rosenfeld, Kindra Clark-Snustad, Kendra J Kamp, et al.
Crohn'S & Colitis 360|February 7, 2025
The Natural History of Inflammatory Bowel Disease in Adults With Common Variable Immunodeficiency: A Case Series From a Single US Tertiary Care CenterPankhuri Jha, Abbinaya Elangovan, Akash Keluth Chavan, et al.
Crohn'S & Colitis 360|December 13, 2024
Association Between Serum Ustekinumab Concentrations and Endoscopic Disease Activity in Moderate-to-Severe Crohn's Disease PatientsDavid M P Di Fonzo, Balqis Alabdulkarim, Russell Yanofsky, et al.
Crohn'S & Colitis 360|January 3, 2025
Early Onset Active Inflammatory Bowel Disease Is Associated With Psychiatric Comorbidities: A Multi-Network Propensity-Matched Cohort StudyAhmed Nadeem, Sydney Donohue, Fatima Zehra Shah, et al.
Crohn'S & Colitis 360|November 29, 2023
Correction to: Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn's Disease: Post Hoc Analyses of VISIBLE Studies
Crohn'S & Colitis 360|November 29, 2023
Dose Escalation of Biologics in Biologic-Naïve Patients With Ulcerative Colitis: Outcomes From the ODESSA-UC StudySabyasachi Ghosh, Niranjan Kathe, Kandavadivu Umashankar, et al.
Crohn'S & Colitis 360|January 24, 2024
Discordance Between Inflammatory Bowel Disease Specialists and Insurance Authorization Denials-A Survey of Specific Inflammatory Bowel Disease Treatment ScenariosAnastasia Naritsin, Neev Mehta, Randall Pellish
Pageof 52